IOANNIS NICOLAOS HOUPIS,KOEN VANDYCK,PIERRE JEAN-MARIE BERNARD RABOISSON,STEFAAN JULIEN LAST
申请号：
BR112012010502
公开号：
BR112012010502A2
申请日:
2010.11.03
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
Inhibitors of HCV replication of formula I including stereochemically isomeric forms, and salts, solvates thereof, wherein R and R′ are, each independently, —CR1R2R3, aryl, heteroaryl or heteroC4-6cycloalkyl, whereby aryl and heteroaryl may optionally be substituted with 1 or 2 substituents selected from halo and methyl. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
